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Contribution of tubuloglomerular feedback to renal arteriolar
angiotensin II responsiveness
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Department of Physiology and Biophysics, University of Nebraska Medical Center, Omaha, Nebraska, USA
Contribution of tubuloglomerular feedback to renal arteriolar angio-
tensin II responsiveness. The purpose of the present study was to test the
hypothesis that a component of the afferent arteriolar vasoconstrictor
response to angiotensin II (Ang II) requires an intact tubuloglomerular
feedback (TGF) mechanism. Enalaprilat-treated male Sprague-Dawley
rats served as tissue donors for study of renal microvascular function using
the in vitro blood-perfused juxtamedullary nephron technique. Arteriolar
lumen diameter responses to exogenous Ang II were determined before
and after TGF blockade (papillectomy or 50 .tM furosemide). Before TGF
blockade, 10 ni Ang II significantly reduced diameters of both mid-
afferent (53 5%) and efferent (43 9%) arterioles. TGF blockade did
not alter baseline diameter of either arteriole, but significantly blunted the
mid-afferent vasoconstriction evoked by 10 nat Ang 11(44 7% inhibition
by papillectomy; 43 10% inhibition by furosemide). Similar behavior
was observed at afferent arteriolar Sites near the glomerulus; however,
ciferent arteriolar Ang II responsiveness was not altered by papillectomy.
The impact of TGF blockade on afferent arteriolar Ang II responsiveness
was most prominent at high peptide concentrations (10 nM), while not
significantly influencing the response to 1 nat Ang II. In contrast, the
afferent vasoconstrictor effect of norepinephrine was unaffected by papil-
lectomy. These data indicate that the vasoconstrictor influence of exoge-
nous Ang II on afferent, but not efferent, arterioles of intact juxtamedul-
lary nephrons includes both TGF-dependent and TGF-independent
components.
TGF sensitivity [7—111, such that increased intrarenal Ang II levels
could result in TGF-mediated afferent vasoconstriction even in
states of constant solute delivery to the macula densa. These latter
two considerations suggest that a component of the afferent
arteriolar vasoconstrictor response to Ang II observed in intact
nephrovascular units might develop through a TGF-dependent
mechanism, such that the TGF mechanism actually enhances the
afferent arteriolar vasoconstrictor impact of Ang II. However, the
involvement and functional relevance of a TGF-dependent com-
ponent of the afferent arteriolar vasoconstrictor response to Ang
II remains uncertain.
The objectives of the current study were to explore the hypoth-
esis that the afferent arteriolar vasoconstrictor response to Ang II
includes a TGF-dependent component and to determine the
segment-specific nature of this phenomenon. These goals were
accomplished through use of the in vitro blood-perfused jux-
tamedullary nephron technique [12], which allows direct micro-
vascular access in an intact tubular environment with a functional
TGF mechanism [13].
Methods
The in vitro blood perfused jwctamedullaiy nephron technique
Angiotensin II (Ang II) is capable of evoking receptor-depen-
dent constriction of both the pre- and postglomerular renal
microvasculature [J—4]. In addition to a direct effect on vascular
smooth muscle cells, the effect of Ang II on afferent arteriolar
resistance in vivo might also reflect, at least in part, the impact of
the peptide on other intrarenal processes which ultimately influ-
ence microvascular function through more indirect mechanisms.
For example, Ang II exerts a potent stimulatory effect on proximal
tubular reabsorption [5]. The reabsorptive response to Ang II
should decrease distal volume delivery and, thus, favor a tubulo-
glomerular feedback (TGF)-mediated afferent arteriolar vasodi-
lation. On the other hand, Hall and Granger [6] postulated that
the potent vasoconstrictor influence of Ang II on efferent arte-
rioles could elevate glomerular filtration rate and distal volume
delivery, thereby activating TGF to cause afferent arteriolar
vasoconstriction. Moreover, Ang II is a primary determinant of
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All procedures utilized in this study were approved by the
Institutional Animal Care and Use Committee of the University
of Nebraska Medical Center. Each experiment utilized two male
Sprague-Dawley rats (300 to 350 g body wt), one as a blood donor
and another as a kidney donor. After anesthetization with sodium
pentobarbital (50 mg/kg i.p.), a catheter was placed in the carotid
artery. All rats were treated with the converting enzyme inhibitor
enalaprilat (2 mg, i.a.) to suppress endogenous Ang II concentra-
tion and its impact on vascular tone and TGF sensitivity. Thirty
minutes later, blood donors were bilaterally nephrectomized
through flank incisions and their blood collected into a hepa-
rinized syringe. Kidney donors were laparotomized and the left
kidney removed. A perfusion cannula introduced via the superior
mesenteric artery into the right renal artery allowed renal perfu-
sion with Tyrode's solution containing 52 glliter bovine serum
albumin and a mixture of L-amino acids [14]. The renal vein was
incised to drain the perfusate and the animal was exsanguinated
into a heparirsized syringe; however, perfusion was maintained
throughout the ensuing dissection procedure. The kidney was
removed and cut longitudinally to expose the pelvic cavity, leaving
the papilla intact within the perfused dorsal two-thirds of the
organ. Small incisions were made in the lateral fornices, allowing
the papilla to be reflected back and retained in that position by
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insect pins. The pelvic mucosa, adipose and connective tissues
which normally cover the inside cortical surface were removed
and the veins were cut open, thus exposing the tubules and
superficial microvasculature of juxtamedullary nephrons. The
portions of the vasculature giving rise to arterioles associated with
these juxtamedullary nephrons were isolated with tight ligatures.
Blood collected from the two rats was prepared for perfusion
according to the following procedure. After centrifugation,
plasma and erythrocytes were collected separately and leukocytes
and platelets were discarded. The plasma was passed through a
0.22 im filter and washed erythrocytes were added to achieve a
hematocrit of 33%. The reconstituted blood was filtered by a 5 Lm
nylon mesh and stirred continuously in a closed reservoir that was
maintained under pressure from a gas tank (95%02:5%C02).
This arrangement provided both tissue oxygenation and the
driving force for perfusion of the kidney.
The Tyrode's perfusate was then replaced by the reconstituted
blood perfusate. Perfusion pressure was measured at the cannula
tip in the renal artery using a P23XL transducer (Gould Inc.,
Oxnard, CA, USA) connected to a polygraph (Grass Instruments,
Quincy, MA, USA), and was maintained at 110 mm Hg through-
out the experiment. The tissue was warmed to 37°C and its surface
continuously bathed with Tyrode's solution containing 10 g/liter
bovine serum albumin. All vasoactive agents were applied to the
tissue by addition to this bathing solution.
Videometric techniques were utilized to measure arteriolar
lumen diameter. The tissue was transilluminated on the fixed
stage of a Nikon Optiphot microscope equipped with a water-
immersion objective (X40, numerical aperture 0.55). Video im-
ages of the microvessels were generated by a Newvicon camera
(Dage-MTI, Michigan City, IN, USA), passed through a time-date
generator (Panasonic, Secaucus, NJ, USA) and an image en-
hancer (MFJ Enterprises, Starkville, MS, USA) and displayed at
a magnification of X 1,400 on a high resolution monitor (Conrac
Display Systems, Covina, CA, USA). The video signal was re-
corded simultaneously on videotape using a SuperVHS videocas-
sette recorder (Panasonic).
A 15-minute equilibration period was followed by execution of
one of the experimental protocols described below. During the
equilibration period, an afferent or efferent arteriole was selected
for study based on visibility and acceptable blood flow. Only
arterioles with rapid flow of erythrocytes were studied, and vessels
were rejected on the basis of inadequate flow if the passage of
single erythrocytes could be discerned. All protocols were de-
signed to assess arteriolar diameter at a single measurement site
under several experimental conditions. Unless otherwise speci-
fied, afferent arteriolar diameter was monitored at sites> 100 jim
upstream from the glomerulus and > 80 jim downstream from the
interlobular artery. Efferent arterioles were studied at sites within
300 jim of the glomerulus, prior to their first branching point.
Experimental protocols
Protocol 1: Effect of papillectomy on Ang 11-induced afferent
arteriolar vasoconstriction. Afferent arteriolar responses to Ang II
(Sigma, St. Louis, MO, USA) were assessed by sequential expo-
sure of the tissue surface to the following bathing solutions: (1)
Tyrode's solution alone, 10 minutes; (2) Tyrode's solution con-
taining either 1 flM (N = 9), 3 flM (N = 9) or 10 tIM (N = 10) Ang
II, three minutes; and (3) Tyrode's solution alone, 10 minutes.
Each afferent arteriole was subjected to this treatment sequence
both before and after resecting the papilla with small scissors, a
method of TGF interruption first employed in this experimental
setting by Sanchez-Ferrer, Roman and Harder [15]. A time
control study was also performed to verify the reproducibility of
afferent arteriolar responses to 10 nM Ang II without the inter-
ruption of TGF (N = 8).
Protocol 2: Effect of furosemide on the afferent arteriolar vasocon-
strictor response to 10 nMAng II. In another group of rats (N =8),
the effect of furosemide on Ang Il-induced afferent arteriolar
vasoconstriction was examined. Afferent arteriolar diameter re-
sponses to 10 nM Ang II were assessed by sequential exposure of
the tissue surface to the following bathing solutions: (1) Tyrode's
solution alone, 10 minutes; (2) Tyrode's solution containing 10 tIM
Ang Ii, three minutes; and (3) Tyrode's solution alone, 10
minutes. Each afferent arteriole was subjected to this treatment
sequence both before and after addition of furosemide to the
perfusate blood at a final concentration of 50 jiM.
Protocol 3: Site-specificity of the TGF-dependent component of
Ang 11-induced vasoconstriction. To examine whether or not TGF
contributes to Ang Il-induced vasoconstriction similarly at the
various renal arteriolar sites, the effect of papillectomy on Ang II
responsiveness was studied in the efferent arteriole (N =7) and at
afferent arteriolar sites within 100 jim of the glomerulus (late
afferent; N = 8). In these experiments, the tissue was exposed to
10 nM Ang II both before and after TGF-blockade achieved by
papillectomy.
Protocol 4: Agonist-specificity of the TGF-dependent component
of afferent arteriolar vasoconstriction. Using another type of vaso-
constrictive agent, the agonist-specificity of the TGF-dependent
component of afferent arteriolar vasoconstriction was examined.
Mid-afferent diameter was monitored in kidneys from rats treated
as described for Protocol 1, except that either 300 (N = 7) or 500
flM (N = 8) norepinephrine (Boehringer Mannheim, Indianapolis,
IN, USA) was substituted for Ang Ii as the vasoconstrictive agent.
These norepinephrine concentrations were chosen based on pre-
vious studies from our laboratory [16, 17]. TGF was blocked by
papillectomy in these experiments.
Data analysis
Microvessel inside diameters were determined from videotaped
images utilizing a digital image-shearing monitor (model 908;
1PM, San Diego, CA, USA). This device was calibrated using a
stage micrometer (smallest division =2 jim) and yielded diameter
measurements reproducible to within 1 jim. Microvessel diameter
was measured at 12 second intervals from a single site along the
vessel length. The average diameter during the final one minute of
each treatment period was utilized for statistical analysis of
responses. Data were analyzed by analysis of variance (ANOVA)
for repeated measures or Friedman repeated measures ANOVA
on ranks, as appropriate, followed by Newman-Keuls test. All of
the statistical computations were performed utilizing the Sigma-
Stat software package (Jandel Scientific, San Rafael, CA, USA).
A P value <0.05 was considered statistically significant. Results
are expressed as mean SE.
Results
The total length of the afferent arterioles included in this study
averaged 560 40 jim. Mid- and late-afferent diameter measure-
ments were made at sites 260 20 and 50 10 jim from the
36 fkenaga et al: TGF and Ang 11-induced vasoconstriction
30
E 25
20
15
E
:3
ci)C
ci)
(a)
cci
10
5
0
Fig. 1. Baseline diameters observed in each group of arterioles both before
(III, intact) and after TGF blockade • papillectomy or , 50 p.M
furosemide). Values are mean SE. Bar groupings denote paired obser-
vations. Time control data (no TGF blockade) were obtained at mid-
afferent arteriolar Sites.
glomerulus, respectively. Efferent arteriolar diameter was mea-
sured at sites 190 30 p.m from the glomerulus, as more proximal
sites were not routinely accessible in these kidneys.
Figure 1 shows the baseline arteriolar diameters before and
during TGF blockade. In this Figure only, mid-afferent diameter
data from kidneys subjected to papillectomy in Protocols 1 and 4
(Ang II and norepinephrine treatment groups) were combined,
since these values did not differ significantly either before or after
papillectomy. Papillectomy did not alter baseline lumen diameter
at any arteriolar site, and there was no effect of furosemide on
mid-afferent diameter. Data from the time control group are also
shown, revealing negligible changes in mid-afferent baseline di-
ameter in intact nephrons within the time frame of the protocols
utilized in these experiments.
Figure 2 summarizes the effect of papillectomy on Ang II-
induced vasoconstriction in mid-afferent arterioles. Addition of 1
nM Ang II to the bathing solution reduced afferent arteriolar
lumen diameter by 2.4 0.5 p.m when the papilla was untouched,
and similar responses were observed after papillectomy (2.2 0.6
p.m decrease in diameter). However, responses to higher concen-
trations of Ang II were suppressed by papillectomy. In intact
nephrovascular units, 3 ni Ang II reduced afferent arteriolar
diameter by 6.3 1.6 p.m. After papillectomy, the same concen-
tration of Ang II only decreased afferent diameter by 4.8 1.3 p.m
(P < 0.05 vs. intact). Similarly, 10 ni Ang II decreased lumen
diameter by 11.1 1.3 p.m before and 6.0 1.1 p.m (P < 0.05 vs.
intact) after papillectomy. Thus, papillectomy attenuated mid-
afferent vasoconstrictor responses to moderate (3 nM) and high
(10 nM) concentrations of Ang II by 33 10% (P < 0.05) and 44
7% (P < 0.05), respectively, whilc the response to 1 nrvi Ang II
was not significantly influenced by papillectomy (8 16%).
Figure 3 shows the effect of furosemide on mid-afferent arte-
riolar vasoconstrictor responses to 10 flM Ang II. For comparison,
responses to 10 nM Ang II in the time control group and
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Fig. 2. Concentration-related effects of papillectomy on mid-afferent diam-
eter responses to Ang II. Symbols are: (LI) intact; (•) papillectomy. Values
are mean SE. Bar groupings denote paired observations. P < 0.05
versus baseline; tP < 0.05 versus intact.
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Fig. 3. Comparison between effects of mechanical (papillectomy) and phar-
macological (50 p.si furosemide) TGF blockade on mid-afferent arteriolar
diameter responses to 10 ni Ang II. Symbols are: (LI) intact; () furo-
semide; (•) papillectomy. Values are mean SE. Time control responses(no TGF blockade) obtained at mid-afferent arteriolar sites are also
depicted. Bar groupings denote paired observations. *p < 0.05 versus
baseline; tp < 0.05 versus intact.
papillectomy group are also shown. Before furosemide treatment,
10 flM Ang II reduced the lumen diameter of mid-afferent
arterioles by 11.7 2.8 p.m. During perfusion with blood contain-
ing 50 p.M furosemide, 10 flM Ang II decreased lumen diameter by
only 7.2 2.0 p.m (P < 0.05 vs. untreated). Thus, furosemide
reduced the mid-afferent diameter response to Ang II by 43
Time Mid- Mid- Late
control afferent afferent afferent Efferent
(N=8) (N=8) (N=43) (N=8) (N=7)
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10% (P < 0.05). The effects of papillectomy and furosemide on
Ang 11-induced mid-afferent arteriolar responses did not differ
significantly. These attenuating effects of papillectomy and furo-
semide on Ang II responsiveness were considered to be distinct
from a time-dependent effect or tachyphylaxis, since the first and
second Ang II treatments in the time control group evoked similar
decreases in mid-afferent diameter (11.0 1.9 and 9.5 1.5 .tm,
respectively).
Figure 4 compares the effect of papillectomy on Ang Il-induced
vasoconstriction at the three arteriolar sites included in this study.
When the papilla was intact, 10 nM Ang II in the bathing solution
decreased lumen diameter at late-afferent and efferent arteriolar
sites by 11.2 1.8 and 8.4 1.8 .tm, respectively. These responses
did not differ significantly from each other or from the responses
of mid-afferent arterioles. At late-afferent arteriolar sites, papil-
lectomy reduced the vasoconstrictive impact of Ang II by 49
10% (6.1 1.5 jim decrease in diameter, P < 0.05 vs. before
papillectomy). In contrast, efferent arteriolar responses to Ang II
after papillectomy (7.1 2.1 jim decrease in diameter) did not
differ from responses observed with the papilla intact. Thus,
papillectomy attenuated Ang Il-induced vasoconstriction at mid-
and late-afferent sites, but had no significant impact on efferent
arteriolar responses to the peptide.
The effect of papillectomy on norepinephrine-induced vasocon-
striction at mid-afferent arteriolar sites is summarized in Figure 5.
A high concentration of norepinephrine (500 nM) applied via the
bathing solution reduced afferent diameter by 11.3 2.0 jim
before papillectomy, and by 13.8 2.6 jim after papillectomy.
Likewise, a moderate concentration (300 nM) of norepinephrine
reduced afferent diameter by 6.3 1.3 jim before papillectomy,
and by 8.3 2.2 jim after papillectomy. Thus, in contrast to the
effects of papillectomy to attenuate afferent arteriolar responses
to Ang II, mid-afferent diameter responses to norepinephrine
were not significantly altered by papillectomy.
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Fig. 4. Impact of papillectomy on mid-afferent, late afferent and efferent
arteriolar diameter responses to 10 nMAng I!. Symbols are: (LI) intact; (•)
papillectomy. Values are mean SE. Bar groupings denote paired
observations. *p < 0.05 versus baseline; tP < 0.05 versus intact.
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Fig. 5. Effects of papillectomy on mid-afferent diameter responses to norepi-
nephrine. Symbols are: (LI) intact; (•) papillectomy. Values are mean
SE. Bar groupings denote paired observations. p < 0.05 versus baseline.
Discussion
Control and maintenance of renal blood flow and glomerular
filtration rate are mediated primarily by active adjustment of
smooth muscle tone in the afferent and efferent arterioles. Like
most vascular beds, the renal microcirculation is subject to the
influence of Ang 11 and other vasoactive hormones. However, a
unique characteristic of renal microvascular control is the involve-
ment of an intrinsic negative feedback system involving tubular
components of the nephron. Since Ang II is a potent modulator of
this TGF mechanism [7—11], it is probable that the peptide exerts
its effect on renal microvessels through TGF-dependent mecha-
nisms as well as through a direct vasoconstrictive action. Results
of the present study reveal that papillectomy and furosemide
attenuate the vasoconstrictor responses of juxtamedullary afferent
arterioles to exogenous Ang II in enalaprilat-treated kidneys.
The present study was designed to maximize our opportunity to
discern any impact of TGF on the renal arteriolar diameter
response to exogenous Ang II. Accordingly, these studies were
performed using tissue from rats treated with enalaprilat, an
angiotensin converting enzyme (ACE) inhibitor. The dose of
enalaprilat employed in this study reduces Ang II levels in the
perfusate blood to undetectable levels and decreases renal Ang II
levels by 60% (unpublished observations). ACE inhibitors and
Ang II receptor blockers markedly attenuate TGF responses [10,
18, 19], indicating that the presence of an intact renin-angiotensin
system is essential for normal operation of the TGF mechanism.
Therefore, in addition to suppressing the direct effect of endog-
enous Aug II on arteriolar tone, inhibition of intrarenal Ang II
formation by enalaprilat should reduce the basal impact of TGF
on the renal microvasculature. Accordingly, neither papillectomy
nor furosemide evoked a significant change in baseline diameter
of any vascular segment in these enalaprilat-treated kidneys.
Taken together with our previous observations that both papillec-
tomy and furosemide increase afferent arteriolar diameter in
kidneys not treated with enalaprilat [20], these data indicate that
converting enzyme inhibition is associated with a suppressed tonic
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influence of TGF on the juxtamedullary microcirculation in our
experimental setting.
Micropuncture studies have revealed that even sub-pressor
doses of exogenous Ang II partially restore the suppressed TGF
responsiveness associated with ACE inhibition 1101, and can
markedly exaggerate TGF sensitivity in untreated control rats [9,
111. Thus, from a baseline condition of enalaprilat-induced sup-
pression of TGF responsiveness, introduction of exogenous Ang
II to the system can be expected to concurrently restore TGF
sensitivity and evoke direct arteriolar vasoconstriction. It is the
sum of these actions which is presumed to underlie the concen-
tration-related decrease in afferent arteriolar diameter evoked by
exogenous Ang II in intact nephrons in both the present study and
previous studies from our laboratory [1, 21].
To distinguish direct and TGF-dependent components of the
vasoconstrictor effect of Ang II, Ang Il-induced responses were
compared before and after papillectomy or furosemide. Acute
surgical papillectomy opens the TGF loop by physical removal of
the loop of Henle, thus interrupting the flow of tubular fluid past
the macula densa cells which likely serve as sensor elements in the
TGF mechanism. In contrast to the mechanical interruption of
TGF achieved by surgical papillectomy, furosemide inhibits the
Na:2Cl :K cotransporter present in the apical membrane of
macula densa cells [22, 231. When present in the tubular lumen at
a concentration of 50 jsM, furosemide inhibits the electrophysi-
ological response of macula densa cells to alterations in tubular
fluid NaCI concentration [22], thereby disrupting the presumed
sensor process involved in TGF [24] and inhibiting the decrease in
afferent arteriolar diameter which normally results from exposure
of the apical aspect of the macula densa cells to isotonic NaCI
[13]. Inclusion of 50 j.LM furosemide in the perfusate blood
(hematocrit = 33%) corresponds to a plasma concentration of 74
/.LM, which is more than double that necessary to evoke a maximal
diuretic response in humans [251. Previous studies from our
laboratory [20] and others [15] have failed to reveal any difference
between the afferent arteriolar effects of furosemide and papillec-
tomy in the perfused juxtamedullary nephron preparation. More-
over, Sanchez-Ferrer et al [15] could detect no effect of either
intervention on arcuate artery reactivity to arterial pressure
changes, which argues against nonspecific actions on vascular
smooth muscle. These observations, together with the similar
impacts of mechanical and pharmacologic TGF blockade to
attenuate Ang II responsiveness in the present study, render
unlikely the possibility that either papillectomy or furosemide
acted through non-specific mechanisms. Rather, these treatments
are assumed to preclude any participation of a TGF-dependent
mechanism in the arteriolar vasoconstrictor response to exoge-
nous Ang II.
Based on these considerations, the component of the Ang II
response which is sensitive to papillectomy or furosemide is
presumed to reflect the TGF-dependent component of the re-
sponse, while any Ang Il-induced decrease in arteriolar diameter
observed after these interventions is assumed to reflect the direct
vasoconstrictor impact of the peptide. Viewed from this perspec-
tive, our data support the contention that the afferent arteriolar
response to Ang II includes a TGF-dependent component. The
involvement of a TGF-dependent component in the afferent
arteriolar response to Ang II is in agreement with the conclusions
of Hall and Granger [6]; however, their clearance studies in the
dog indicated that preglomerular Ang II responsiveness was
abolished completely by ureteral occlusion during mannitol diure-
sis. Results of the present study indicate that TGF blockade in the
rat attenuates, but does not abolish, afferent arteriolar vasocon-
strictor responses to Ang 11.
Any TGF-dependent impact of Ang II on vascular resistance
should be primarily limited to those vascular segments which serve
as TGF effector element(s). The primary effector element of the
TGF mechanism is generally considered to be that portion of the
afferent arteriole which lies in closest proximity to the attendant
macula densa. However, upstream (mid-afferent) participation in
TGF-mediated vasoconstrictor responses might be achieved by
conduction of electrophysiological events between adjacent
smooth muscle cells or by development of an ascending myogenic
response [26]. Consistent with these postulates, a significant
TGF-dependent component of the afferent arteriolar Ang II
response was detected at sites located several hundred microme-
ters from the glomerulus. Although the impact of TGF blockade
on juxtamedullary afferent arteriolar responses to perfusion pres-
sure alterations diminishes with distance from the glomerulus in
this experimental setting, [20, 27], a distance-related impact of
TGF on Ang II responsiveness could not be discerned in the
present study. Nevertheless, we cannot rule out the possibility that
the most distal portion of the juxtamedullary afferent arteriole
displays an enhanced TGF-dependent component of Ang II
responsiveness. In contrast to the behavior of afferent arterioles,
the efferent arteriolar response to Ang II was unaltered by
papillectomy. Thus, the efferent vasoconstrictor response to the
peptide appears to develop independent of TGF, as suggested
previously by Hall and Granger [6]. This observation likely reflects
the fact that efferent arterioles are not primary effector elements
in the TGF mechanism [28].
Although papillectomy suppressed afferent arteriolar vasocon-
strictor responses to Ang II, norepinephrine responses were
unaffected. Unlike Ang II, norepinephrine does not increase TGF
sensitivity [291. Accordingly, under conditions of enalaprilat-
induced suppression of TGF sensitivity, the afferent arteriolar
response to norepinephrine in intact nephrovascular units should
primarily reflect direct vasoconstriction. As subsequent papillec-
tomy should not substantially reduce the impact of TGF on the
microvasculature in the continued setting of suppressed Ang II
levels, it is not surprising that this maneuver had no significant
impact on the vasoconstrictor response to norepinephrine. Thus,
the failure of papillectomy to suppress the NE response argues
against a non-specific (TGF-independent) impact of papillectomy
on afferent arteriolar responsiveness to vasoconstrictor agonists,
and suggests that the TGF-dependent component of the afferent
arteriolar response to Ang II reflects the impact of the peptide on
TGF sensitivity. Although the mechanism by which arteriolar
responses to Ang II are enhanced through a TGF-dependent
process remains speculative, an interaction of the peptide with
adenosine or other substances which impact on feedback respon-
siveness could be involved [29, 30].
Taken together, the results of the present study suggest that an
Ang Il-stimulated amplification of TGF response sensitivity po-
tentiates the direct afferent arteriolar vasoconstrictor response to
the peptide. We cannot estimate the extent to which this phenom-
enon contributes to Ang II responses in vivo, as the results
presented here may overestimate the TGF-dependent component
by eliminating some negative feedback mechanisms which regu-
late the renin-angiotensin system and its impact on TGF. Results
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of the concentration-response experiments indicate that a variable
fraction of the response to Ang II is due to TGF. The direct
vasoconstrictor response predominated at low peptide concentra-
tions, while proportionately larger components of the response
were TGF-dependent as Ang 11 concentration was progressively
elevated. Although these observations suggest that the Ang II
sensitivities of the direct vascular and TGF-mediated responses
differ quantitatively, the functional relevance of this distinction
remains uncertain. Nevertheless, even during TGF blockade, Ang
II evoked concentration-dependent afferent arteriolar vasocon-
strictor responses which were substantial enough to be expected
to significantly influence glomerular blood flow and filtration
dynamics.
In summary, the results of the present study demonstrate by
direct methods that Ang TI-induced afferent, but not effcrent,
arteriolar vasoconstriction is attenuated by TGF blockade. In
contrast, afferent arteriolar responses to norepinephrine were not
diminished by TGF blockade. These observations suggest that the
afferent arteriolar response to Ang II includes both direct and
TGF-dependent components. The ability of Ang II to amplify
TGF response sensitivity likely underlies the TGF-dependent
component of the vasoconstrictor response to the peptide.
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